Today: 20 May 2026
Browse Category

LSE:VOD.L 3 November 2025 - 3 March 2026

Vodafone turns to Amazon Leo satellites to plug remote 5G gaps in Europe and Africa

Vodafone turns to Amazon Leo satellites to plug remote 5G gaps in Europe and Africa

Vodafone will use Amazon’s low Earth orbit satellites to connect remote 4G and 5G masts, starting in Germany in 2026, then expanding across Europe and Africa via Vodacom. The service promises up to 1 Gbps download and 400 Mbps upload speeds. Vodafone says the satellite link will help keep sites online during fibre outages. Amazon Leo’s constellation currently has over 200 satellites in orbit.
Vodafone stock price dips after Amazon Leo satellite deal; VOD.L investors eye May results

Vodafone stock price dips after Amazon Leo satellite deal; VOD.L investors eye May results

Vodafone shares fell about 1% to 113.4 pence in early London trading after announcing a satellite backhaul deal with Amazon’s low-Earth-orbit network, Amazon Leo. The company expects to connect its first sites in Germany in 2026, expanding later into Africa via Vodacom. Investors are focused on execution and potential impacts on capital expenditure and cash flow ahead of FY26 results in May.
2 March 2026
Vodafone share price: Buyback kicks off, but Germany recovery is the next test for VOD.L

Vodafone share price: Buyback kicks off, but Germany recovery is the next test for VOD.L

Vodafone (VOD.L) bought 27.1 million shares this week as its new buyback began, with the stock closing Friday up 1.47% at 110.6p after a sharp drop the day before. Investors remain focused on Germany’s service-revenue growth and the pace of buybacks ahead of Monday’s open. The company maintained full-year guidance after reporting 5.4% group service revenue growth in Q3, with Germany up 0.7%.
8 February 2026
Vodafone share price today: VOD edges up near a 52-week high as Centrica deal and buyback keep focus on Feb 5 update

Vodafone share price today: VOD edges up near a 52-week high as Centrica deal and buyback keep focus on Feb 5 update

Vodafone shares rose 0.1% to 106.45 pence in early London trading, near a 52-week high, after announcing a four-year UK enterprise deal with Centrica and a new subsea fibre project in Greece. The company repurchased 2.52 million shares on Jan. 27. Investors await Vodafone’s third-quarter trading update and interim dividend schedule on Feb. 5.
29 January 2026
Vodafone share price edges up after fresh buyback disclosure — here’s what traders watch next

Vodafone share price edges up after fresh buyback disclosure — here’s what traders watch next

Vodafone shares rose 0.1% to 102.05 pence in early London trading after the company bought back nearly 2.85 million shares at an average price of 102.02 pence. The shares, acquired from Merrill Lynch International, will be held in treasury. Vodafone closed Monday at 102.00 pence, up 1.19% from Friday. The company’s next trading update is scheduled for Feb. 5.
20 January 2026
Vodafone share price nudges lower as buyback rolls on; UBS keeps Sell call on VOD.L

Vodafone share price nudges lower as buyback rolls on; UBS keeps Sell call on VOD.L

Vodafone shares fell 0.4% to 98.3 pence by 0932 GMT in London, after a 2.6% drop Tuesday, despite another buyback announcement. The company repurchased over 5.2 million shares on Jan. 13, adding to its treasury stock. Investors are awaiting Vodafone’s trading update on Feb. 5 for further direction. UBS maintained its “sell” rating but raised the target price to 82 pence.
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

London Markets Slip as FTSE 100 Falters Ahead of BoE Verdict

The FTSE 100 closed at 9,701, down 0.2%, pausing near record highs as gains in oil and financial stocks were offset by losses in mining and retail. The FTSE 250 slipped 0.3%. Investors grew cautious ahead of Thursday’s Bank of England meeting. Vodafone fell over 5% after a broker downgrade, while BP rose 1% after a $1.5 billion US asset sale.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Go toTop